Argon plasma coagulation for superficial esophageal squamous-cell carcinoma in high-risk patients

Table 2 Patients characteristics

No.	Age(yr)	Sex	Depth	Time (min)	Times	Hospitalization days	Interval until recurrence (mo)	Retreatment	Illness
1	66	M	m	14	1	11	-	-	After right lung resection, thrombophlebitis1
2	59	M	m	22	4	35	-	-	LC (HCV), esophageal varices
			m
3	68	M	m	26	4	68	7	APC	LC (alcoholic), IHD, remnant stomach
4	67	M	m1	30	1	12	-	-	OMI (three vessel stenosis)1
5	67	M	m	15	1	53	-	-	LC (HCV), HCC, esophageal varices, DM
6	79	M	m	10	1	13	-	-	Dementia
7	66	M	sm	34	2	47	-	-	LC (alcoholic), esophageal varices, DM
8	60	M	m	16	2	14	-	-	Arrhythmia, mitral regurgitation
9	74	M	m1	14	3	11	-	-	Cerebral infarction
10	66	M	m2	36	2	17	-	-	Post tongue cancer operation
11	71	M	m1	28	2	12	-	-	Multiple SESC
			m1
			m1
			m1
12	68	F	m1	15	1	0	-	-	Post colon cancer operation
13	76	M	m1	15	1	5	-	-	lesion of near after ESD scar
14	73	M	m1	15	1	0	-	-	Recurrence after EMR
15	70	M	m1	25	2	16	-	-	IHD1
16	57	M	sm1	12	4	12	3	APC	LC, recurrence after CRT
17	80	F	m2	15	2	14	-	-	Senior age, IHD, recurrence after CRT

¹Anticoagulant therapy; m: Mucosa; sm: Submucosa; m1: Epithelium; m2: Lamina propria mucosae; sm1: Superficial layer of submucosa; APC: Argon plasma coagulation; LC: Liver cirrhosis; IHD: Ischemic heart disease; OMI: Old myocardial infarction; HCC: Hepatocellular carcinoma; DM: Diabetes mellitus; SESC: Superficial esophageal squamous-cell carcinoma; ESD: Endoscopic submucosal dissection; EMR: Endoscopic mucosal resection; CRT: Chemoradiotherapy.